PAS
CVS icon

Park Avenue Securities’s CVS Health CVS Stock Holding History

Park Avenue Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Buy
54,798
+5,158
+10% +$460K 0.04% 354
2026
Q1 		$3.56M Sell
49,640
-373
-0.7% -$28.7K 0.03% 398
2025
Q4 		$3.97M Buy
50,013
+1,367
+3% +$108K 0.03% 348
2025
Q3 		$3.67M Buy
48,646
+4,005
+9% +$274K 0.03% 387
2025
Q2 		$3.08M Buy
44,641
+18,751
+72% +$1.23M 0.03% 383
2025
Q1 		$1.75M Buy
25,890
+1,244
+5% +$74.4K 0.02% 433
2024
Q4 		$1.11M Buy
24,646
+1,359
+6% +$76.2K 0.01% 706
2024
Q3 		$1.46M Sell
23,287
-2,292
-9% -$134K 0.02% 520
2024
Q2 		$1.51M Sell
25,579
-1,406
-5% -$88K 0.02% 502
2024
Q1 		$2.15M Buy
26,985
+827
+3% +$63.2K 0.03% 395
2023
Q4 		$2.06M Sell
26,158
-1,153
-4% -$82.1K 0.03% 369
2023
Q3 		$1.91M Buy
27,311
+1,753
+7% +$124K 0.03% 347
2023
Q2 		$1.77M Buy
25,558
+1,465
+6% +$104K 0.03% 355
2023
Q1 		$1.79M Sell
24,093
-2,832
-11% -$237K 0.03% 313
2022
Q4 		$2.51M Buy
26,925
+4,000
+17% +$386K 0.04% 245
2022
Q3 		$2.19M Buy
22,925
+2,549
+13% +$252K 0.04% 247
2022
Q2 		$1.89M Buy
20,376
+2,540
+14% +$248K 0.04% 283
2022
Q1 		$1.8M Buy
17,836
+237
+1% +$24.9K 0.03% 307
2021
Q4 		$1.82M Buy
17,599
+2,036
+13% +$188K 0.03% 295
2021
Q3 		$1.32M Buy
15,563
+1,857
+14% +$156K 0.03% 329
2021
Q2 		$1.14M Buy
13,706
+665
+5% +$54.5K 0.02% 341
2021
Q1 		$981K Sell
13,041
-7,110
-35% -$518K 0.02% 346
2020
Q4 		$1.38M Buy
20,151
+1,176
+6% +$76.5K 0.04% 216
2020
Q3 		$1.11M Buy
18,975
+2,408
+15% +$150K 0.04% 220
2020
Q2 		$1.08M Buy
+16,567
New +$1.04M 0.04% 185
2020
Q1 		– Sell
-2,876
Closed -$214K – 352
2019
Q4 		$214K Buy
+2,876
New +$202K 0.01% 559
2019
Q2 		– Sell
-6,084
Closed -$330K – 295
2019
Q1 		$330K Buy
+6,084
New +$376K 0.02% 291
2017
Q3 		– Sell
-2,684
Closed -$213K – 141
2017
Q2 		$213K Buy
+2,684
New +$212K 0.02% 191
2016
Q3 		– Sell
-2,108
Closed -$200K – 52
2016
Q2 		$200K Sell
2,108
-57
-3% -$5.68K 0.03% 93
2016
Q1 		$227K Sell
2,165
-1,577
-42% -$153K 0.04% 72
2015
Q4 		$366K Buy
+3,742
New +$366K 0.08% 39

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Park Avenue Securities's CVS Position: Q2 2026 in Review

Park Avenue Securities increased its CVS Health (CVS) stake by 10% in Q2 2026, buying an estimated $460K and bringing the position to 54,798 shares worth $5.67M. The position accounts for 0.04% of the portfolio, ranked #354.

Park Avenue Securities first reported a position in CVS in Q4 2015 and has held it in 31 quarters since. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Park Avenue Securities held 54,798 shares of CVS Health worth $5.67M as of Q2 2026.
  • Park Avenue Securities bought 5,158 CVS Health shares in Q2 2026, an estimated $460K.
  • CVS Health made up 0.04% of Park Avenue Securities's portfolio in Q2 2026, its #354 holding.
  • Park Avenue Securities first reported a position in CVS Health in Q4 2015 and has held it in 31 quarters since.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.